S1

(redirected from Form S-1)
Also found in: Financial, Wikipedia.

S1

Symbol for first heart sound.

S1

the first heart sound in the cardiac cycle, occurring at the outset of ventricular systole. It is associated with closure of the mitral and tricuspid valves and is synchronous with the apical pulse. Auscultated at the apex, it is longer, and lower than the second sound (S2), which follows it. The sound of the mitral valve is loudest at the apex of the heart, and that of the tricuspid valve is loudest at the left sternal border in the fourth intercostal space. See also lubb.

S1, S2, . . .

symbols for sacral nerves.

S1

First heart sound, which corresponds to the closure of the mitral and tricuspid valves, which is a long, low, “lubb” that occurs during systole. See S2, S3, S4.

S1

Abbreviation for first heart sound.
References in periodicals archive ?
The company had filed the Form S-1 resale registration statement (S-1) filed on 15 April 2017 and its common stock are now eligible to be sold in the market by certain existing shareholders listed in the registration statement.
Medpace Holdings, Inc, a clinical contract research organisation, has filed a registration statement on Form S-1 with the US Securities and Exchange Commission regarding a proposed initial public offering of its common stock, it was announced on Friday.
When an insurer registers a product using Form S-1, the insurer then must comply with the Form 10-Q, Form 10-K and other form filing requirements listed in Section 13 of the Securities Exchange Act of 1934, Roth writes.
Biotech products company Portage Biotech Inc (OTC:PTGEF) on Friday announced a registration statement on Form S-1 with the US Securities and Exchange Commission (the SEC) relating to a planned offering of its common shares.
Molecular diagnostics company Great Basin Scientific Inc (NasdaqGS:GBSN) said on Tuesday that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (SEC) for its planned equity offering.
Gene therapy company Spark Therapeutics (NasdaqGS:ONCE) said on Wednesday that it has filed a registration statement on Form S-1 with the US Securities and Exchange Commission relating to a proposed public offering of shares of its common stock.
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) stated on Thursday that its Form S-1 registration statement will be declared effective at 16:00 EST on 19 April 2013.
M2 EQUITYBITES-May 2, 2012-Delphi announces filing of resale shelf registration statement on Form S-1 with SEC(C)2012 M2 COMMUNICATIONS http://www.